BERKELEY, Calif.--(BUSINESS WIRE)--Dynavax Technologies (Nasdaq:DVAX) today announced that Dr. Martin E. Sanders has been appointed Executive Vice President and Chief Development Officer. Sanders will direct Dynavax’s product development programs, including pre-clinical, process development, clinical, and regulatory activities.
